type: timeline_event
President Trump invoked the Defense Production Act to designate glyphosate — the active ingredient in Bayer/Monsanto's Roundup herbicide — as essential to national defense, citing its role in maintaining domestic agricultural production. The executive order, developed under the coordination of U.S. Department of Agriculture Secretary Brooke Rollins, directed federal agencies to support the domestic production and supply chain of glyphosate. Bayer AG, the German pharmaceutical and chemical conglomerate that acquired Monsanto in 2018, was the sole remaining large-scale domestic producer of glyphosate, making the DPA designation a de facto order benefiting a single foreign-owned corporation. Legal analysts immediately noted that the designation could provide Bayer with a military contractor defense, potentially shielding the company from over 100,000 pending cancer lawsuits brought by individuals alleging that Roundup exposure caused non-Hodgkin lymphoma.
The invocation created an extraordinary fracture within the Trump administration's own coalition. Robert F. Kennedy Jr., serving as Secretary of Health and Human Services, had built his public career in significant part on campaigning against glyphosate and Roundup, characterizing the herbicide as a carcinogenic threat to public health. The DPA order directly contradicted Kennedy's longstanding position and the broader Make America Healthy Again (MAHA) movement that had been a significant component of Trump's political base. Kennedy's public response was notably muted, raising questions about whether his influence within the administration had been subordinated to corporate lobbying interests. The spectacle of a president who campaigned on health freedom using wartime emergency powers to protect a chemical that his own health secretary had long denounced illustrated the profound contradictions within the administration's policy framework.
The legal implications of the DPA designation were potentially enormous. Under the government contractor defense doctrine, companies producing goods under federal direction or contract can claim immunity from state tort liability, provided they followed government specifications. By designating glyphosate production as a matter of national defense, the Trump administration potentially created a pathway for Bayer to argue that its continued production of Roundup was undertaken at the direction of the federal government, thereby shielding the company from billions of dollars in jury verdicts and settlements. Bayer had already paid over $10 billion to settle Roundup cancer claims but still faced a massive backlog of pending litigation. The use of Cold War-era emergency powers to provide potential tort immunity to a foreign-owned multinational corporation — for a commercial agricultural product with no plausible connection to military operations — represented what legal scholars characterized as the most expansive and legally dubious invocation of the Defense Production Act in its 75-year history.